[1]Ricard-Blum S. The collagen family[J]. Cold Spring HarborPerspectives in Biology, 2011, 3(1): a004978.[2]Shoulders M D, Raines R T. Collagen structure and stability[J].Annual Review of Biochemistry, 2009, 78: 929-958.[3]Varani J, Dame M K, Rittie L, et al. Decreased collagen productionin chronologically aged skin: roles of age-dependent alteration in fibroblastfunction and defective mechanical stimulation[J]. American Journalof Pathology, 2006, 168(6): 1861-1868.[4]Davison-Kotler E, Marshall W S, García-Gareta E. Sources of collagenfor biomaterials in skin wound healing[J]. Bioengineering, 2019,6(3): 56.[5]Hua C, Zhu Y, Xu W, et al. Characterization by high-resolution crystalstructure analysis of a triple-helix region of human collagen typeIII with potent cell adhesion activity[J]. Biochemical and BiophysicalResearch Communications, 2019, 508(4): 1018-1023.[6]Bai M, Kang N, Xu Y, et al . The influence of tag sequence on recombinanthumanized collagen (rhCol) and the evaluation of rhCol onSchwann cell behaviors[J]. Regen Biomater. 2023,10,:rbad089.[7]王建,范毓慧,李丹凤, 等.重组人源化胶原蛋白基于体外水平的护肤功效研究[J]. 日用化学工业( 中英文), 2024, 54(9): 1030-1038.[8]陈传秀. 重组Ⅲ型人源化胶原蛋白化妆品的体外抗衰功效研究[J]. CDCST 2024, 1(2):38–42.[9]Chen C X, Zhang Y Y, Yang J B, et al. An overview of progress inthe application of recombinant collagen in cosmetics[J]. The Journal ofDermatologic Science and Cosmetic Technology, 2024, 1(4): 100059.9[10]Zhang Z, Yang W, Yang J, et al. Evaluation of the safety and functionaleffects of recombinant humanized type III collagen in food toxicology[J]. Front. Med. 13:1765276.[11]国家药品监督管理局. 重组Ⅲ型人源化胶原蛋白冻干纤维获批上市[EB/OL]. (2021-06-29)[2026-05-28]. https://www.nmpa.gov.cn/zhuanti/cxylqx/cxylqxlm/20210629141635133.html.[12]Wang Q , An Q , Wang Y ,et al.Development and mechanistic investigationof recombinant type Ⅲ humanized collagen gel for mid-facialsoft tissue repair[J].Collagen and Leather, 2025, 14(2).[13] 龙存林, 张敏娟, 任戬, 等. 重组胶原蛋白在医疗器械领域的应用进展[J]. 中国医疗器械杂志, 2025, 49(6): 640-646.[14] 盖潇潇, 孙晓霞, 马文倩, 等. 探究医用重组人源胶原蛋白功能敷料在伤口愈合中的作用[J]. 中国医疗器械杂志, 2025, 49(4): 415-422.[15]Huang J H, Lei X L, Huang Z W, et al. Bioprinted gelatin-recombinanttype Ⅲ collagen hydrogel promotes wound healing[J]. InternationalJournal of Bioprinting, 2022, 8(2): 517.[16]Yang L, Wu H S, Lu L, et al. A tailored extracellular matrix (ECM)-mimetic coating for cardiovascular stents by stepwise assembly ofhyaluronic acid and recombinant human type Ⅲ collagen[J]. Biomaterials,2021, 276: 121055.[17]Li H, You S, Yang X, et al. Injectable recombinant human collagen-derived material with high cell adhesion activity limits adverseremodelling and improves pelvic floor function in pelvic floor dysfunctionrats[J]. Biomaterials Advances, 2022, 134: 112715.[18]Shuai X, Kang N, Li Y, et al. Recombination humanized type IIIcollagen promotes oral ulcer healing[J]. Oral Diseases, 2024, 30: 1286-1295.[19]Liu X, Li H, Wang T, et al. Recombinant humanized collagen typeIII with high antitumor activity inhibits breast cancer cells autophagy,proliferation, and migration through DDR1[J]. Int J Biol Macromol,2023,15(243):125-130.[20]Zeng H, Li H, Wang L, et al. Recombinant humanized type III collageninhibits ovarian cancer and induces protective anti-tumor immunityby regulating autophagy through GSTP1[J]. Mater Today Bio, 2024,28:101220.[21]Liu W, Hu C, Long L, et al. An injectable carrier for spatiotemporaland sequential release of therapeutic substances to treat myocardial infarction[J]. Journal of Controlled Release : Official Journal of the ControlledRelease Society, 2024,365:29-42.[22]国家药品监督管理局药品审评中心. 山西锦波生物医药股份有限公司重组Ⅲ型人源化胶原蛋白冻干纤维药用辅料登记[DB/OL].(2025-09)[2026-05-28]. https://www.cde.org.cn.